An Effectiveness, Safety and Quality of Life Measures With Hydromorphone HCL, Dilaudid CR (Controlled Release)

NCT00399048 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis, Knee
Osteoarthritis, Hip

Interventions

DRUG: OROS hydromorphone HCL ; OxyContin

Sponsor

Alza Corporation, DE, USA